-transparent.png){kind=logo}
In cultured bovine adrenocortical cells, loss of 17 alpha-hydroxylase activity was observed after incubation with 3-methylcholanthrene (3-MC). The suppression of 17 alpha-hydroxylase by 3-MC was rapid (50% loss of activity in 10 hr at 1 microM 3-MC), did not exhibit a lag period, and was not affected by cycloheximide. Direct effects of 3-MC on 17 alpha-hydroxylase were observed only at high concentrations, but the concentration for 50% loss of activity was 0.3 microM when 3-MC was added for 24 hr prior to assay of 17 alpha-hydroxylase. High concentrations (to 40 microM) of substrate (progesterone), did not affect the loss of activity due to 3-MC. Loss of 17 alpha-hydroxylase activity was specific; 11 beta-hydroxylase was unaffected and cell growth was unaltered. However, 22-amino-23,24-bisnorchol-5-en-3 beta-ol, an inhibitor of 17 alpha-hydroxylase, partially prevented the loss of 17 alpha-hydroxylase at 1-30 nM. 3-MC is thought to induce cytochrome P-450s via a receptor with high affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). TCDD was without effect on 17 alpha-hydroxylase over the range of 10 nM to 10 microM. Benz[a]anthracene, 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene, chrysene, and methylphenanthrenes suppressed 17 alpha-hydroxylase at high concentrations (10-50 microM for 50% loss of activity). Some steroids that lack a substituent at position 17 also caused loss of 17 alpha-hydroxylase. Like 17 alpha-hydroxylase, bovine adreno-cortical cell AHH was found to be suppressed by exposure to 3-MC. Compounds that caused loss of 17 alpha-hydroxylase caused loss of AHH, with a similar order of potency and at similar concentrations. Suppression of AHH by 3-MC did not require protein synthesis and was prevented by an inhibitor of enzymatic activity, alpha-naphthoflavone. This implies a degree of similarity of the cytochrome P-450s for 17 alpha-hydroxylase and adrenal AHH, but the activities were shown to be likely due to different enzymes. The suppression of 17 alpha-hydroxylase and AHH by 3-MC appears not to occur by a receptor-mediated mechanism but to be similar to the suppression of 11 beta-hydroxylase and 21-hydroxylase by steroid pseudosubstrates previously observed.
P J Hornsby, and
K A Aldern, and
S E Harris
June 1975,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
P J Hornsby, and
K A Aldern, and
S E Harris
January 1975,
Acta biologica et medica Germanica,
P J Hornsby, and
K A Aldern, and
S E Harris
May 1987,
Molecular endocrinology (Baltimore, Md.),
P J Hornsby, and
K A Aldern, and
S E Harris
January 1974,
Biochemical and biophysical research communications,
P J Hornsby, and
K A Aldern, and
S E Harris
August 1989,
Bulletin of environmental contamination and toxicology,
P J Hornsby, and
K A Aldern, and
S E Harris
February 2006,
Cancer research,
P J Hornsby, and
K A Aldern, and
S E Harris
March 1974,
Molecular pharmacology,
P J Hornsby, and
K A Aldern, and
S E Harris
February 1976,
The Journal of investigative dermatology,
P J Hornsby, and
K A Aldern, and
S E Harris
March 1984,
The British journal of dermatology,
P J Hornsby, and
K A Aldern, and
S E Harris
February 1974,
The New England journal of medicine,
